These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24523418)

  • 1. Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.
    Okutsu M; Call JA; Lira VA; Zhang M; Donet JA; French BA; Martin KS; Peirce-Cottler SM; Rembold CM; Annex BH; Yan Z
    Circ Heart Fail; 2014 May; 7(3):519-30. PubMed ID: 24523418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.
    Li P; Waters RE; Redfern SI; Zhang M; Mao L; Annex BH; Yan Z
    Am J Pathol; 2007 Feb; 170(2):599-608. PubMed ID: 17255328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli.
    Yu Z; Li P; Zhang M; Hannink M; Stamler JS; Yan Z
    PLoS One; 2008 May; 3(5):e2086. PubMed ID: 18461174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.
    Call JA; Chain KH; Martin KS; Lira VA; Okutsu M; Zhang M; Yan Z
    Circ Heart Fail; 2015 Jan; 8(1):188-97. PubMed ID: 25504759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1β triggers muscle-derived extracellular superoxide dismutase expression and protects muscles from doxorubicin-induced atrophy.
    Yamada M; Okutsu M
    J Physiol; 2023 Nov; 601(21):4699-4721. PubMed ID: 37815420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.
    Bacurau AV; Jardim MA; Ferreira JC; Bechara LR; Bueno CR; Alba-Loureiro TC; Negrao CE; Casarini DE; Curi R; Ramires PR; Moriscot AS; Brum PC
    J Appl Physiol (1985); 2009 May; 106(5):1631-40. PubMed ID: 19179649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
    Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.
    Geng T; Li P; Yin X; Yan Z
    Am J Pathol; 2011 Apr; 178(4):1738-48. PubMed ID: 21435455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH2 restores exhaustive exercise-induced mitochondrial dysfunction in skeletal muscle.
    Zhang Q; Zheng J; Qiu J; Wu X; Xu Y; Shen W; Sun M
    Biochem Biophys Res Commun; 2017 Apr; 485(4):753-760. PubMed ID: 28249782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.
    Heineke J; Auger-Messier M; Xu J; Sargent M; York A; Welle S; Molkentin JD
    Circulation; 2010 Jan; 121(3):419-25. PubMed ID: 20065166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance exercise attenuates skeletal muscle oxidative stress, systemic pro-inflammatory state, and cachexia in Walker-256 tumor-bearing rats.
    Padilha CS; Borges FH; Costa Mendes da Silva LE; Frajacomo FTT; Jordao AA; Duarte JA; Cecchini R; Guarnier FA; Deminice R
    Appl Physiol Nutr Metab; 2017 Sep; 42(9):916-923. PubMed ID: 28475846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study.
    Gielen S; Sandri M; Kozarez I; Kratzsch J; Teupser D; Thiery J; Erbs S; Mangner N; Lenk K; Hambrecht R; Schuler G; Adams V
    Circulation; 2012 Jun; 125(22):2716-27. PubMed ID: 22565934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle.
    Wafi AM; Hong J; Rudebush TL; Yu L; Hackfort B; Wang H; Schultz HD; Zucker IH; Gao L
    J Appl Physiol (1985); 2019 Feb; 126(2):477-486. PubMed ID: 30462567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations.
    Pin F; Busquets S; Toledo M; Camperi A; Lopez-Soriano FJ; Costelli P; Argilés JM; Penna F
    Oncotarget; 2015 Dec; 6(41):43202-15. PubMed ID: 26636649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.
    Tzanis G; Dimopoulos S; Agapitou V; Nanas S
    Curr Heart Fail Rep; 2014 Mar; 11(1):70-9. PubMed ID: 24293034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training.
    Fukai T; Siegfried MR; Ushio-Fukai M; Cheng Y; Kojda G; Harrison DG
    J Clin Invest; 2000 Jun; 105(11):1631-9. PubMed ID: 10841522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
    Nambu H; Takada S; Fukushima A; Matsumoto J; Kakutani N; Maekawa S; Shirakawa R; Nakano I; Furihata T; Katayama T; Yamanashi K; Obata Y; Saito A; Yokota T; Kinugawa S
    Eur J Pharmacol; 2020 Jan; 866():172810. PubMed ID: 31738936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.
    Buck M; Chojkier M
    EMBO J; 1996 Apr; 15(8):1753-65. PubMed ID: 8617220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.